Outcome analysis of patients with primary breast cancer initially treated at a certified academic breast unit

Breast

Volumn 21, Issue 3, 2012, Pages 303-308

  Heil, J ^a   Gondos, A ^a   Rauch, G ^a   Marme F ^a   Rom, J ^a   Golatta, M ^a   Junkermann, H ^a   Sinn, P ^a   Aulmann, S ^a   Debus, J ^a   Hof, H ^a   Schutz F ^a   Brenner, H ^a   Sohn, C ^a   Schneeweiss, A ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Breast cancer; Certified breast unit; Health services research; Prognostic factor; Survival

Indexed keywords

HORMONE RECEPTOR;

ADULT; AGE; AGED; ARTICLE; BREAST CANCER; CANCER CONTROL; CANCER GRADING; CANCER INVASION; CANCER RADIOTHERAPY; CARCINOMA IN SITU; DISEASE FREE SURVIVAL; GERMANY; HUMAN; MAJOR CLINICAL STUDY; METASTASIS; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PARTIAL MASTECTOMY; PRIMARY TUMOR; PRIORITY JOURNAL; PROGNOSIS; PROSPECTIVE STUDY; TREATMENT OUTCOME;

EID: 84862513829     PISSN: 09609776     EISSN: 15323080     Source Type: Journal    
DOI: 10.1016/j.breast.2012.01.009     Document Type: Article

References (29)

1. Haberland J., Bertz J., Wolf U., Ziese T., Kurth B.M. German cancer statistics 2004. BMC Cancer 2010, 10:52.
2. Jemal A., Siegel R., Ward E., Hao Y., Xu J., Thun M.J. Cancer statistics, 2009. CA Cancer J Clin 2009, 59(4):225-249.
3. La Vecchia C., Bosetti C., Lucchini F., Bertuccio P., Negri E., Boyle P., et al. Cancer mortality in Europe, 2000-2004, and an overview of trends since 1975. Ann Oncol 2009, 21(6):1323-1360.
4. Greco M., Marotti L. Background to Eusoma guidelines and statements. Eur J Cancer 2006, 42(14):2200-2204.
5. Kreienberg R., Kopp I., Albert U., Bartsch H., Beckmann M., Berg D., et al. Interdisciplinary S3 guidelines for the diagnosis, treatment and follow-up care of breast cancer 2008, Deutsche Krebsgesellschaft, Munich.
6. Brucker S.Y., Bamberg M., Jonat W., Beckmann M.W., Kammerle A., Kreienberg R., et al. Certification of breast centres in Germany: proof of concept for a prototypical example of quality assurance in multidisciplinary cancer care. BMC Cancer 2009, 9:228.
7. Blamey R.W., Cataliotti L. EUSOMA accreditation of breast units. Eur J Cancer 2006, 42(10):1331-1337.
8. Fitzgibbons P.L., Page D.L., Weaver D., Thor A.D., Allred D.C., Clark G.M., et al. Prognostic factors in breast cancer. College of American Pathologists Consensus Statement 1999. Arch Pathol Lab Med 2000, 124(7):966-978.
9. Martin M., Gonzalez Palacios F., Cortes J., de la Haba J., Schneider J. Prognostic and predictive factors and genetic analysis of early breast cancer. Clin Transl Oncol 2009, 11(10):634-642.
10. Remmele W., Stegner H.E. Recommendation for uniform definition of an immunoreactive score (IRS) for immunohistochemical estrogen receptor detection (ER-ICA) in breast cancer tissue. Pathologe 1987, 8(3):138-140.
11. Kalbfleisch J., Prentice R. The statistical analysis of failure time data. Wiley series in probability and statistics 2002, Wiley-Interscience, Hoboken, New Jersey. 2nd ed.
12. Ederer F., Axtell L.M., Cutler S.J. The relative survival rate: a statistical methodology. Natl Cancer Inst Monogr 1961, 6:101-121.
13. Corazziari I., Quinn M., Capocaccia R. Standard cancer patient population for age standardising survival ratios. Eur J Cancer 2004, 40(15):2307-2316.
14. Verdecchia A., Francisci S., Brenner H., Gatta G., Micheli A., Mangone L., et al. Recent cancer survival in Europe: a 2000-02 period analysis of EUROCARE-4 data. Lancet Oncol 2007, 8(9):784-796.
15. Brenner H., Gondos A., Arndt V. Recent major progress in long-term cancer patient survival disclosed by modeled period analysis. J Clin Oncol 2007, 25(22):3274-3280.
16. Gondos A., Bray F., Brewster D.H., Coebergh J.W., Hakulinen T., Janssen-Heijnen M.L., et al. Recent trends in cancer survival across Europe between 2000 and 2004: a model-based period analysis from 12 cancer registries. Eur J Cancer 2008, 44(10):1463-1475.
17. Gondos A., Bray F., Hakulinen T., Brenner H. Trends in cancer survival in 11 European populations from 1990 to 2009: a model-based analysis. Ann Oncol 2009, 20(3):564-573.
18. Altekruse S., Kosary C., Krapcho M. SEER cancer statistics review, 1975-2007 2010, National Cancer Institute. http://seer.cancer.gov/csr/1975_2007/.
19. Blamey R.W., Hornmark-Stenstam B., Ball G., Blichert-Toft M., Cataliotti L., Fourquet A., et al. ONCOPOOL - a European database for 16,944 cases of breast cancer. Eur J Cancer 2010, 46(1):56-71.
20. Hiripi E., Gondos A., Emrich K., Holleczek B., Katalinic A., Luttmann S., et al. Survival from common and rare cancers in Germany in the early 21st century. Ann Oncol 2012, 23:472-479.
21. Allemani C., Storm H., Voogd A.C., Holli K., Izarzugaza I., Torrella-Ramos A., et al. Variation in 'standard care' for breast cancer across Europe: a EUROCARE-3 high resolution study. Eur J Cancer 2010, 46(9):1528-1536.
22. Berrino F., De Angelis R., Sant M., Rosso S., Bielska-Lasota M., Coebergh J.W., et al. Survival for eight major cancers and all cancers combined for European adults diagnosed in 1995-99: results of the EUROCARE-4 study. Lancet Oncol 2007, 8(9):773-783.
23. Richards M.A. The size of the prize for earlier diagnosis of cancer in England. Br J Cancer 2009, 101(Suppl. 2):S125-S129.
24. Thomson C.S., Forman D. Cancer survival in England and the influence of early diagnosis: what can we learn from recent EUROCARE results?. Br J Cancer 2009, 101(Suppl. 2):S102-S109.
25. Christensen L.H., Engholm G., Ceberg J., Hein S., Perfekt R., Tange U.B., et al. Can the survival difference between breast cancer patients in Denmark and Sweden 1989 and 1994 be explained by patho-anatomical variables?-A population-based study. Eur J Cancer 2004, 40(8):1233-1243.
26. Christensen L.H., Engholm G., Cortes R., Ceberg J., Tange U., Andersson M., et al. Reduced mortality for women with mammography-detected breast cancer in east Denmark and south Sweden. Eur J Cancer 2006, 42(16):2773-2780.
27. Sant M., Allemani C., Capocaccia R., Hakulinen T., Aareleid T., Coebergh J.W., et al. Stage at diagnosis is a key explanation of differences in breast cancer survival across Europe. Int J Cancer 2003, 106(3):416-422.
28. Gondos A., Arndt V., Holleczek B., Stegmaier C., Ziegler H., Brenner H. Cancer survival in Germany and the United States at the beginning of the 21st century: an up-to-date comparison by period analysis. Int J Cancer 2007, 121(2):395-400.
29. Swan J., Breen N., Coates R.J., Rimer B.K., Lee N.C. Progress in cancer screening practices in the United States: results from the 2000 national health Interview Survey. Cancer 2003, 97(6):1528-1540.